APA (7th ed.) Citation

Jr, L. L., M, L., M, T., E, S., L, L., P, J., . . . SM, d. l. M. (2009). Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis. Journal of Alzheimer's disease : JAD, 16(4), 715. https://doi.org/10.3233/JAD-2009-0984

Chicago Style (17th ed.) Citation

Jr, Lyn-Cook LE, et al. "Hepatic Ceramide May Mediate Brain Insulin Resistance and Neurodegeneration in Type 2 Diabetes and Non-alcoholic Steatohepatitis." Journal of Alzheimer's Disease : JAD 16, no. 4 (2009): 715. https://doi.org/10.3233/JAD-2009-0984.

MLA (9th ed.) Citation

Jr, Lyn-Cook LE, et al. "Hepatic Ceramide May Mediate Brain Insulin Resistance and Neurodegeneration in Type 2 Diabetes and Non-alcoholic Steatohepatitis." Journal of Alzheimer's Disease : JAD, vol. 16, no. 4, 2009, p. 715, https://doi.org/10.3233/JAD-2009-0984.